Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FRVD2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,853
Award facts
- Contract value 100% obligated
- $11,853.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,853.15 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this delivery order based on its established federal procurement track record and capabilities to meet military medical supply requirements. The company's DLA prime contract encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines, enabling it to support the Defense Health Agency and other government healthcare systems. This particular delivery order for Trelegy Ellipta—a combination respiratory medication used to treat chronic obstructive pulmonary disease—reflects the company's ongoing role in supplying critical pharmaceutical commodities to federal military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FRVD2?
SPE2DB25FRVD2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FRVD2 worth?
The government has obligated $11,853 on SPE2DB25FRVD2.
Is contract SPE2DB25FRVD2 an order under another contract?
Yes. SPE2DB25FRVD2 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVD2 competed?
The extent of competition for SPE2DB25FRVD2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award